<DOC>
	<DOC>NCT00528255</DOC>
	<brief_summary>This study will provide pharmacokinetic data for the MVI 100 (100 mcg) misoprostol vaginal insert when administered to nulliparous women at term gestation requiring cervical ripening and induction of labor.</brief_summary>
	<brief_title>Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100)</brief_title>
	<detailed_description>PK study in women requiring cervical ripening.</detailed_description>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Pregnant women at ≥36 weeks 0 days inclusive gestation; Aged 18 years or older; Candidate for pharmacologic induction of labor; Singleton pregnancy; Baseline modified Bishop score &lt;4 (see Appendix B); Nulliparous (nulliparous is defined as no previous births live or dead after 24 weeks gestation); Written informed consent. Women with hemoglobin level &lt; 11.0 g/dL (confirmed within one week of study drug insertion); Women in active labor; Presence of uterine or cervical scar or uterine abnormality e.g. bicornate uterus. Biopsies, including cone biopsy of the cervix, are permitted; Administration of oxytocin or any cervical ripening or labor inducing agents (including mechanical methods) or a tocolytic drug within 7 days prior to enrollment. Magnesium sulfate is permitted if prescribed as treatment for preeclampsia or pregnancy inducted hypertension; Severe preeclampsia marked by CNS findings, HELLP syndrome, or other endorgan affliction; Suspected or confirmed cephalopelvic disproportion and/or fetal malpresentation; Diagnosed fetal abnormalities; Suspected or confirmed intrauterine growth retardation (less than 10% estimated fetal weight for dates); Any evidence of fetal compromise at baseline (e.g., nonreassuring fetal heart rate pattern or meconium staining); Receipt of NSAID (including aspirin) within 4 hours of study treatment; Ruptured membranes ≥48 hours prior to the start of treatment or suspected chorioamnionitis; Fever (oral or aural temperature &gt; 37.5C); Any condition in which vaginal delivery is contraindicated e.g., placenta previa or any unexplained genital bleeding at any time after 24 weeks during this pregnancy; Known or suspected allergy to misoprostol, dinoprostone, other prostaglandins or any of the excipients; Any condition urgently requiring delivery; Unable to comply with the protocol.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>cervical ripening</keyword>
	<keyword>induction of labor</keyword>
</DOC>